Aberrant TET1 methylation closely associated with CpG island methylator phenotype in colorectal cancer

被引：0
|
作者：
Ichimura, Norihisa [1 ]
Shinjo, Keiko [1 ]
Ohka, Fumiharu [1 ]
Katsushima, Keisuke [1 ]
Hatanaka, Akira [1 ]
Tojo, Masayuki [2 ]
Shimizu, Yasuhiro [3 ]
Yamamoto, Eiichiro [4 ]
Suzuki, Hiromu [4 ]
Kondo, Yutaka [1 ]
机构：
[1] Nagoya City Univ, Dept Epigen, Nagoya, Aichi, Japan
[2] Showa Univ, Sch Med, Div Gastroenterol, Tokyo 142, Japan
[3] Aichi Canc Ctr, Dept Gastroenterol Surg, Nagoya, Aichi 464, Japan
[4] Sapporo Med Univ, Dept Mol Biol, Sapporo, Hokkaido, Japan
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.AM2015-1054
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1054
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Preference of aberrant methylation of promoter region in multiple genes indicates presence of Cpg island methylator phenotype in colorectal cancers
    Hokazono, Koji
    Ueki, Takashi
    Konomi, Hiroyuki
    Mibu, Ryuichi
    Tanaka, Masao
    GASTROENTEROLOGY, 2007, 132 (04) : A320 - A321
  • [22] Global differences in the prevalence of the CpG island methylator phenotype of colorectal cancer
    Shailesh Mahesh Advani
    Pragati Shailesh Advani
    Derek W. Brown
    Stacia M. DeSantis
    Krittiya Korphaisarn
    Helena M. VonVille
    Jan Bressler
    David S. Lopez
    Jennifer S. Davis
    Carrie R. Daniel
    Amir Mehrvarz Sarshekeh
    Dejana Braithwaite
    Michael D. Swartz
    Scott Kopetz
    BMC Cancer, 19
  • [23] CpG Island Methylator Phenotype in Colorectal Cancers Comparison of the New and Classic CpG Island Methylator Phenotype Marker Panels
    Lee, Sun
    Cho, Nam-Yun
    Yoo, Eun Joo
    Kim, Jung Ho
    Kang, Gyeong Hoon
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2008, 132 (10) : 1657 - 1665
  • [24] Global differences in the prevalence of the CpG island methylator phenotype of colorectal cancer
    Advani, Shailesh Mahesh
    Advani, Pragati Shailesh
    Brown, Derek W.
    DeSantis, Stacia M.
    Korphaisarn, Krittiya
    VonVille, Helena M.
    Bressler, Jan
    Lopez, David S.
    Davis, Jennifer S.
    Daniel, Carrie R.
    Sarshekeh, Amir Mehrvarz
    Braithwaite, Dejana
    Swartz, Michael D.
    Kopetz, Scott
    BMC CANCER, 2019, 19 (01)
  • [25] Are clinicopathological features of colorectal cancers with methylation in half of CpG island methylator phenotype panel markers different from those of CpG island methylator phenotype-high colorectal cancers?
    Bae, Jeong Mo
    Rhee, Ye-Young
    Kim, Kyung Ju
    Wen, Xianyu
    Song, Young Seok
    Cho, Nam-Yun
    Kim, Jung Ho
    Kang, Gyeong Hoon
    HUMAN PATHOLOGY, 2016, 47 (01) : 85 - 94
  • [26] CpG island methylator phenotype in bladder cancer
    Chung, Woonbok
    Bondaruk, Jolanta
    Zhang, Nianxiang
    Jelinek, Jaroslav
    Estecio, Marcos
    Liang, Shoudan
    Czerniak, Bogdan
    Issa, Jean-Pierre J.
    CANCER RESEARCH, 2012, 72
  • [27] Tetranucleotide and Low Microsatellite Instability Are Inversely Associated with the CpG Island Methylator Phenotype in Colorectal Cancer
    Meessen, Sabine
    Currey, Nicola
    Jahan, Zeenat
    Parker, Hannah W.
    Jenkins, Mark A.
    Buchanan, Daniel D.
    Hopper, John L.
    Segelov, Eva
    Dahlstrom, Jane E.
    Kohonen-Corish, Maija R. J.
    CANCERS, 2021, 13 (14)
  • [28] BRAF mutation is associated with the CpG island methylator phenotype in colorectal cancer from young patients
    Ang, Pei Woon
    Li, Wei Qi
    Soong, Richie
    Iacopetta, Barry
    CANCER LETTERS, 2009, 273 (02) : 221 - 224
  • [29] LINE-1 hypomethylation is inversely associated with microsatellite instability and CpG island methylator phenotype in colorectal cancer
    Ogino, Shuji
    Kawasaki, Takako
    Nosho, Katsuhiko
    Ohnishi, Mutsuko
    Suemoto, Yuko
    Kirkner, Gregory J.
    Fuchs, Charles S.
    INTERNATIONAL JOURNAL OF CANCER, 2008, 122 (12) : 2767 - 2773
  • [30] Opinion - CpG island methylator phenotype in cancer
    Issa, JP
    NATURE REVIEWS CANCER, 2004, 4 (12) : 988 - 993
12345